ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > Xanthine dehydrogenase

Xanthine dehydrogenase

概要

Name:Xanthine dehydrogenase
Target Synonym:XD,XDH,Xanthine Dehydrogenase,Xanthene Dehydrogenase,XAN1,XDHA,XOR,Xanthine oxidase,EC 1.7.2.2,EC:1.17.3.2,EC 1.17.1.4,EC:1.17.1.4,XO,Xanthine oxidoreductase,Xanthine dehydrogenase/oxidase
Number of Launched Drugs:5
Number of Drugs in Clinical Trials:7
Lastest Research Phase:Approved

Product Inquiry

* We couldn't find what you're looking for. You can let us help by filling the form below. Our tech team will get back to you shortly.
* This form is only used to collect product demand consultation. All the information will be kept strictly confidential.
Product inquiry collection form
*
*
*
*
*
*
*
*
*
ACRO Quality

公開薬物情報

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Allopurinol BW-56-158; ATH-008; NSC-1390 Approved Sebela Ireland Ltd Lopurin, Zyloric, Zyloprim, 路必利 United States Gout; Hyperuricemia Casper Pharma Llc 1966-08-19 Hand-Foot Syndrome; Hyperuricemia; Diabetes Mellitus, Type 2; Liver Cirrhosis; Fibrosis; Nephrolithiasis; Angina Pectoris; Gout; Renal Insufficiency, Chronic; Inflammation Details
Febuxostat TMX-67; TEI-6720; TMX-67XR Approved Teijin Pharma 风定宁, Uloric, 优立通, Adenuric, Febric, 瑞扬, Feburic, Febutaz EU Gout Menarini International Operations Luxembourg Sa 2008-04-21 Hyperuricemia; Kidney Calculi; Pain; Kidney Diseases; Tumor Lysis Syndrome; Hypertension; Angina Pectoris; Cardiovascular Diseases; Gout Details
Allopurinol sodium Approved Mylan Nv Aloprim United States Gout; Hyperuricemia Mylan Institutional Inc 1996-05-17 Hyperuricemia; Gout; Leishmaniasis Details
Allopurinol/Benzbromarone Approved Hyperuricemia Details
Topiroxostat FYX-051; SK-0910 Approved Fuji Yakuhin Co Ltd Uriadec, Topiloric Japan Gout; Hyperuricemia Fuji Yakuhin Co Ltd, Sanwa Kagaku Kenkyusho Co Ltd 2013-06-28 Hyperuricemia; Diabetic Nephropathies; Gout Details

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
Tigulixostat LC-350189; IBI-350; LR-19074 Phase 3 Clinical Lg Life Sciences Ltd Hyperuricemia; Heart Diseases; Gout Details
Oxipurinol (XORTX Therapeutics) XRx-008; XRx-101 Phase 2 Clinical Xortx Therapeutics Polycystic Kidney Diseases Details
THDBH-151 THDBH151; THDBH-151 Phase 2 Clinical Dongbao Zixing (Hangzhou) Biological Medicine Co Ltd Gout Details
TMX-049 TMX-049; TMX-049DN Phase 2 Clinical Teijin Pharma Diabetic Nephropathies Details
Xrx-221 Phase 1 Clinical Xortx Therapeutics Diabetic Nephropathies Details
IBI-128 IBI128; IBI-128 Phase 1 Clinical Innovent Biologics(Suzhou) Co Ltd Hyperuricemia; Arthritis, Gouty; Metabolic Diseases; Gout Details
HZN-457 HZN-457 Phase 1 Clinical Horizon Therapeutics Ireland Dac Details

This web search service is supported by Google Inc.

totopphone